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2 
ABSTRACT  1 
 Epidemiologic studies have shown that nutrition is a key factor in modulating 2 
sporadic colorectal carcinoma (CRC) risk. Aromatic plants of the genus Salvia (sage) 3 
have been attributed many medicinal properties, which include anticancer activity. In 4 
the present study, the antiproliferative and pro-apoptotic effects of water extracts of 5 
Salvia fruticosa (SF) and Salvia officinalis (SO) and of their main phenolic compound 6 
rosmarinic acid (RA) were evaluated in two human colon carcinoma-derived cell lines, 7 
HCT15 and CO115, which have different mutations in the MAPK/ERK and PI3K/Akt 8 
signalling pathways. These pathways are commonly altered in CRC leading to increased 9 
proliferation and inhibition of apoptosis. Our results show that SF, SO and RA induce 10 
apoptosis in both cell lines, whereas cell proliferation was inhibited by the two sage 11 
extracts only in HCT15. SO, SF and RA inhibited ERK phosphorylation in HCT15 and 12 
had no effects on Akt phosphorylation in CO115 cells. The activity of sage extracts 13 
seems to be due, at least in part, to the inhibition of MAPK/ERK pathway.   14 
 15 
Introduction 16 
 Cancer is an important health problem and one of the most common forms is 17 
colorectal carcinoma (CRC). Phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-18 
activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signalling 19 
pathways play critical roles in cell proliferation and survival and are frequently 20 
activated in CRC (1-3). Deregulation of these pathways is also thought to determine 21 
response to treatment (4). Mutations of KRAS and BRAF in sporadic CRC [70-80% of 22 
total cases (5)] are alternative, where the former constitutively activates both 23 
MAPK/ERK and PI3K/Akt pathways and the latter activates MAPK/ERK pathway (3, 24 
4, 6-8). As presented by Schubbert et al. (9), mutations in CRC of either KRAS or 25 
Page 2 of 32
http://mc.manuscriptcentral.com/nc
Nutrition and Cancer: An International Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Xavier  
 
3 
BRAF genes occur in 32% and 14% of cases, respectively. Studies have also shown that 26 
CRC is frequently associated with mutations in genes that encode for PI3K, PI3KCA, 27 
and PTEN (an endogenous inhibitor of PI3K activity), resulting in an overexpression of 28 
Akt (10-13). Considering the high incidence of CRC, inhibitors of these pathways are 29 
actively being searched for use in the control of cancer progression (14-16).  30 
Epidemiologic studies have shown that western type diets, poor in vegetables 31 
and fruits, are risk factors known associated with CRC, suggesting that nutritional 32 
factors may also be preventive and also helpful in the control of cancer (17-19). In fact 33 
green and black tea consumption has been shown to be effective in the initiation, 34 
promotion and progression stages of carcinogenesis, although effects on colon cancer 35 
are inconclusive (20). Plants of the genus Salvia (sage) such as Salvia miltiorrhiza and 36 
Salvia menthaefolia have also been suggested to have anticancer properties based on 37 
antiproliferative activity on tumor cells (21, 22). In addition, reactive oxygen species 38 
(ROS) have been reported to play a role in signalling transduction enhancing 39 
proliferation and survival of cancer cells. Antioxidant phytochemicals through their 40 
ROS scavenging activity, may suppress altered redox-sensitive signalling events in 41 
cancer (23, 24).   42 
 Salvia fruticosa (SF) and Salvia officinalis (SO), poorly studied with regard to 43 
their anticancer activity, are mediterranean medicinal and aromatic plants which contain 44 
rosmarinic acid (RA; Fig. 1) as major phenolic compound in their water extracts. RA 45 
constitutes about 58% of all phenolic compounds present in SF water extract and 70% 46 
in SO water extract (25, 26). This phenolic compound has high antioxidant and anti-47 
inflammatory activities (22, 27), but little is known about its effects on cancer cells and 48 
especially on CRC.  49 
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4 
 In the present study, we report on the antiproliferative and pro-apoptotic effects 50 
of two Salvia water extracts, SF and SO, and their major phenolic compound, RA, in 51 
two human colon cancer-derived cell lines, HCT15 and CO115, through effects on the 52 
MAPK/ERK and PI3K/Akt pathways and caspase mediated apoptosis. These two cell 53 
lines possess different activating mutations in these two pathways: HCT15 has a KRAS 54 
(G13D) mutation (28) whereas CO115 has a BRAF (V599E) mutation (29).  55 
In view of these genetic differences we further speculate on the mechanisms 56 
behind the antiproliferative and pro-apoptotic effects of sage extracts and RA and the 57 
involvement of PI3K/Akt and MAPK/ERK signalling pathways in these effects.  58 
 59 
Material and Methods 60 
 61 
Reagents and Plant Extracts  62 
 All reagents and chemicals used were of analytical grade. Wortmannin (W), 63 
rosmarinic acid (RA) and staurosporine were purchased from Sigma-Aldrich (St. Louis, 64 
MO, USA) and PD-98059 (PD) was from Calbiochem (San Diego, CA, USA). The 65 
primary antibodies anti-phospho-Akt (Ser473), anti-Akt total, anti-phospho-PTEN 66 
(Ser380/Thr382/383), anti-PTEN total, anti-p44/42 MAPK total and anti-cleaved 67 
caspase-9 (Asp315) were purchased from Cell Signaling (Danvers, MA, USA), the anti-68 
phospho-ERK and caspase-3 (H-277) were from Santa Cruz Biotechnology, Inc. (Santa 69 
Cruz, CA, USA) and the anti-β-actin from Sigma-Aldrich. The secondary antibodies 70 
HRP donkey anti-rabbit and sheep anti-mouse were from GE Healthcare (Bucks, UK).  71 
 The water extracts of Salvia fruticosa and Salvia officinalis were prepared as 72 
previously described by Lima et al. (30), by pouring boiling water onto the dried plant 73 
material (at ratio of 150ml of water to each 2g of plant) and allowing to steep for 5min. 74 
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5 
After filtering, the water extract was lyophilized to dryness. The extracts of both sages 75 
were made using batches of the plants which composition, in terms of phenolics 76 
compounds, have already been published (25, 26). In brief, SF water extract contain as 77 
major phenolic compound rosmarinic acid (RA; 71.5µg/ml), 6-hydroxyluteolin-7-78 
glucoside (22.7µg/ml), a not identified flavone heteroside (28.6µg/ml) and the 79 
remaining phenolic compounds representing 0.8µg/ml. SO water extract contain as 80 
major phenolic compounds RA (52.0µg/ml), luteolin-7-glucoside (19.7µg/ml) and the 81 
remaining phenolic compounds representing 2.7µg/ml.  82 
Stocks solutions of PD and W were made in dimethyl sulfoxide (DMSO) and 83 
aliquots were kept at -20ºC. Therefore, DMSO (0.5%) was included in cell culture for 84 
the other conditions (controls and extracts/RA) to exclude any possible DMSO effect.  85 
 86 
Cell culture  87 
 HCT15 and CO115 human colon carcinoma-derived cell lines were a gift from 88 
Dr. Raquel Seruca (IPATIMUP, University of Porto, Portugal) and were maintained in 89 
culture at 37ºC in a humidified 5% CO2 atmosphere in RPMI-1640 medium (Sigma-90 
Aldrich) supplemented with 10mM HEPES, 0.1mM pyruvate, 1% antibiotic-91 
antimycotic solution (Sigma-Aldrich) and 10% fetal bovine serum (FBS; EU standard, 92 
Cambrex, Verviers, Belgium). Cells were seeded onto six well plates at a density of 93 
0.75 x10
5
 (HCT15) and 1.0 x10
5
 (CO115) cells/well. Incubations with different 94 
concentrations of sage extracts and RA were performed in serum free medium for 48h 95 
to analyze BrdU incorporation and TUNEL positive cells, and for 24h for western blot 96 
analysis. 97 
 98 
Assessment of proliferation by BrdU incorporation 99 
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6 
 Preliminary experiments using the MTT assay were performed in order to 100 
choose concentrations of SF and SO extracts that inhibited around 50% cell 101 
proliferation without cytotoxic effects. RA was tested in similar concentrations to the 102 
ones found in the extracts at the concentrations used and also did not induce cytotoxic 103 
effect. After 45h of treatment with sage extracts or RA at different concentrations, 104 
bromodeoxyuridine (BrdU; Sigma-Aldrich) was added to the culture medium in order to 105 
give a final concentration of 10µM, and then incubated for another 3h. Both adherent 106 
and non-adherent cells were collected from each sample, fixed with 4% 107 
paraformaldehyde for 15min at room temperature and then attached into a polylysine 108 
treated slide using a Shandon Cytospin (Thermo Fisher Scientific Inc, Waltham MA, 109 
USA). Cells were incubated with HCl 2M for 20min, washed in PBS containing 0.5% 110 
Tween-20 and 0.05% BSA (TPBS-B) and then incubated with monoclonal mouse anti-111 
BrdU antibody (DakoCytomation, Glostrup, Denmark) for 1h at room temperature. 112 
After washing in TPBS-B, cells were incubated with anti-mouse IgG FITC-conjugated 113 
secondary antibody (Sigma-Aldrich) for 1h at room temperature, washed again and then 114 
incubated with Hoechst for nuclei staining. The percentage of proliferating cells was 115 
calculated as the ratio between BrdU positive cells and total number of cells (nuclei 116 
staining with Hoechst), from a count higher than 500 cells per slide under a fluorescent 117 
microscope. Results are presented as mean ± SEM of at least three independent 118 
experiments. 119 
 120 
Assessment of apoptosis by TUNEL assay 121 
 Cells treated as above for 48 h were collected (both floating and attached cells) 122 
and fixed with 4% paraformaldehyde for 15min at room temperature and then attached 123 
into a polylysine treated slide using a Shandon Cytospin. Cells were washed in PBS and 124 
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7 
permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 2min on ice. TUNEL 125 
(TdT mediated dUTP Nick End Labelling) assay was performed using a kit from Roche 126 
(Mannheim, Germany), following the manufacture’s instructions. Cells were incubated 127 
with Hoechst for nuclei staining. The percentage of apoptotic cells was calculated from 128 
the ratio between TUNEL positive cells and total number of cells (nuclei staining with 129 
Hoechst), from a count higher than 500 cells per slide under a fluorescent microscope. 130 
Results are presented as mean ± SEM of at least three independent experiments. 131 
 132 
Protein extraction and western blotting 133 
 After 24h of treatment with sage extracts or RA at the highest concentration used 134 
in the BrdU and TUNEL assay, cells were washed with PBS and lysed for 15min at 4ºC 135 
with ice cold RIPA buffer (1% NP-40 in 150mM NaCl, 50mM Tris (pH 7.5), 2mM 136 
EDTA), supplemented with 20mM NaF, 1mM phenylmethylsulfonyl fluoride (PMSF), 137 
20mM Na2V3O4 and protease inhibitor cocktail (Roche). Protein concentration was 138 
quantified using a Bio-Rad DC protein assay (Bio-Rad Laboratories, Inc., Hercules, 139 
CA, USA) and BSA as a protein standard. Twenty micrograms of protein for each 140 
sample were separated by SDS gel electrophoresis and then electroblotted to a Hybond-141 
P polyvinylidene difluoride membrane (GE Healthcare). Membranes were blocked in 142 
TPBS (PBS with 0.05% Tween-20) containing 5% (w/v) non-fat dry milk or BSA, 143 
incubated with the primary antibody and followed by the secondary antibody 144 
conjugated with IgG horseradish peroxidase. Membranes were washed 3 times with 145 
TPBS between the different incubations. Immunoreactive bands were detected using the 146 
Immobilon solutions (Millipore, Billerica, MA, USA) under a chemiluminescence 147 
detection system, the Chemi Doc XRS (Bio-Rad Laboratories, Inc.). Band area intensity 148 
was quantified using the Quantity One software from Bio-Rad. β-actin was used as a 149 
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8 
loading control. Results are presented as mean ± SEM of at least three independent 150 
experiments.  151 
 152 
Statistical analysis 153 
 One-way ANOVA followed by the Student-Newman-Keuls test was used to 154 
perform statistical analysis for BrdU, TUNEL and western blot data. GraphPad Prism 155 
4.0 software (San Diego, CA, USA) was used and P-values ≤0.05 were considered 156 
statistically significant.  157 
 158 
Results  159 
 160 
Effects on cell proliferation   161 
 To test the effects of SF, SO and RA on cell proliferation of human colon cancer 162 
cells, two different colon carcinoma-derived cell lines, HCT15 and CO115, were used.  163 
 Based on preliminary experiments using the MTT assay (data not shown), where 164 
cells were incubated with several concentrations of sage extracts for 48h, concentrations 165 
of each extract that were not cytotoxic and inhibited cell proliferation around 50% were 166 
chosen for the subsequent studies. Since RA is the main phenolic compound of these 167 
extracts, we also tested RA in similar concentrations to the ones found in the extracts 168 
under our experimental conditions.  169 
 The effects of sage extracts and RA on cell proliferation of both cell lines were 170 
tested using the BrdU incorporation assay. As shown in Fig. 2A, a significant inhibition 171 
of HCT15 cell proliferation by both SF and SO was observed at all concentrations 172 
tested. Levels of BrdU incorporation significantly decreased from 26.2% in the control 173 
to 4.7% in HCT15 cells treated with 50µg/ml of SF and SO extracts. In CO115 cells, SF 174 
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9 
and SO did not inhibit significantly cell proliferation (Fig. 2B). No significant inhibition 175 
of cell proliferation was observed in both cell lines treated with RA (Fig. 2). Comparing 176 
the effects of sage extracts in the two cell lines, we observed that SF extract was 177 
somewhat more active than SO and HCT15 cells were more sensitive to the sage 178 
extracts.   179 
 180 
Effects on apoptosis   181 
 The ability of SF, SO and RA to induce apoptosis in human colon carcinoma-182 
derived cells were studied using the TUNEL assay. As shown in Fig. 3, both Salvia 183 
extracts and RA significantly induced apoptosis in a concentration dependent manner in 184 
both HCT15 and CO115 cells. Apoptotic cells in HCT15 increased from 0.4% in the 185 
control to 6.6%, 5.8% and 2.5% in SF, SO and RA treatments, respectively, at the 186 
higher concentrations tested (Fig. 3A). In CO115 cells, apoptotic cells increased from 187 
1.8% in the control to 6.8%, 3.8% and 3.6% in the conditions treated with the higher 188 
concentrations tested of SF, SO and RA, respectively (Fig. 3B). Since the basal levels of 189 
apoptosis were higher in the CO115 cell line, overall it seems that the HCT15 cells were 190 
more sensitive to the extracts and RA. Again, SF extract showed to be more active than 191 
SO extract and RA alone.  192 
The involvement of caspases 3 and 9 in the apoptosis induction by sage extracts 193 
and RA was also studied by western blot. After 24h of treatment with the highest 194 
concentrations used of SF, SO and RA, we did not observe cleaved caspase-9 and 195 
caspase-3 in either of cell lines, in contrast with the reference compound, staurosporine 196 
(data not shown).  197 
 198 
Effects on MAPK/ERK pathway   199 
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10 
 The effects of sage extracts and RA for 24h were studied on the MAPK/ERK 200 
pathway by western blot. Salvia extracts and RA significantly decreased phospho-ERK 201 
protein levels in HCT15 cells (Fig. 4A) while no effects were observed in CO115 cells 202 
(Fig. 4B). The reference inhibitor of phospho-ERK, PD-98059 (PD) was effective in 203 
both cell lines (Fig. 4), in a similar extension than SF, SO and RA in HCT15 cells.  204 
 205 
Effects on PI3K/Akt pathway   206 
 The effects of sage extracts and RA on the expression of phospho-Akt and 207 
phospho-PTEN (a negative regulator of PI3K/Akt pathway) were also tested. Phospho-208 
Akt was observed in CO115, however was not detected in HCT15, in medium with and 209 
without serum (data not shown). Neither of the Salvia extracts nor RA inhibited 210 
significantly the expression of phospho-Akt in CO115 cells (Fig. 5A). A significant 211 
inhibition of Akt phosphorylation was observed for the reference PI3K inhibitor, 212 
wortmannin (W). HCT15 cells expressed phospho-PTEN and this expression was not 213 
significantly changed by Salvia extracts, RA or W (Fig. 5B). CO115 cells did not 214 
express phospho-PTEN or total PTEN, in medium with and without serum (data not 215 
shown).  216 
 217 
Discussion 218 
 In order to assess the potential of sage in the control of CRC progression, the 219 
antiproliferative and pro-apoptotic effects of Salvia fruticosa (SF) and Salvia officinalis 220 
(SO) water extracts and their main phenolic compound, rosmarinic acid (RA), were 221 
studied in two human colon carcinoma-derived cell lines, HCT15 and CO115. Both 222 
sage water extracts (SF and SO) were effective in inhibiting proliferation in a 223 
concentration-dependent manner in HCT15 but not in CO115 cells. SF, SO and RA 224 
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11 
induced apoptosis. SF was more effective than SO with regard to both antiproliferative 225 
and proapoptotic effects. To identify the bioactive compound behind these effects, 226 
sage’s major phenolic compound (RA), was tested individually at concentration similar 227 
to those present in the extracts. However, RA was found not to have antiproliferative 228 
activity but to be proapoptotic in both cell lines, although at less extent than sage 229 
extracts. In view of these results, it seems that other active compounds present in the 230 
extracts may be responsible for the antiproliferative and proapoptotic effects of SF and 231 
SO.  232 
 The two cell lines used harbor different activating mutations: HCT15 has a 233 
KRAS (G13D) activating mutation (28) with potential to constitutively activate both 234 
PI3K/Akt and MAPK/ERK pathways, whereas CO115 harbors a BRAF (V599E) 235 
mutation (29) which affects the MAPK/ERK pathway. The highest sensitivity of 236 
HCT15 could be a result of these genetic differences. HCT15 cells, even though 237 
presenting an activating mutation of the RAS oncogene, did not express phospho-Akt 238 
possibly as a consequent of the high levels of the strong negative regulator of this 239 
pathway, phospho-PTEN, found in this cell line. In these cells, the antiproliferative 240 
effects of SF and SO correlate with an inhibition of phospho-ERK. However, RA 241 
showed a significant inhibition of phospho-ERK without inhibiting HCT15 cell 242 
proliferation. Inhibition of phospho-ERK seems, therefore, not to be the only factor 243 
involved in inhibition of cell proliferation in this cell line. Our findings are in agreement 244 
with previous studies (6, 31), which have shown that an inhibition of MAPK/ERK 245 
pathway in KRAS mutated cell lines is not sufficient to inhibit cell proliferation. 246 
Therefore, the KRAS mutated HCT15 cells do not depend exclusively on MAPK/ERK 247 
pathway to proliferate and, as a result, SF and SO seem also to be inhibiting other 248 
proliferation pathways, which in these cells do not include Akt phosphorylation (Fig. 6). 249 
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12 
In CO115 cells, where SF and SO did not have antiproliferative effect, there was 250 
no inhibition of phospho-ERK or phospho-Akt. RA also did not inhibit proliferation of 251 
CO115 cells. However, in contrast to the effects on the other cell line, RA was without 252 
effect on phospho-ERK. Inhibition of MAPK/ERK pathway by sage extracts and RA in 253 
HCT15 and not CO115 indicates that the effect may be upstream of BRAF and could be 254 
on KRAS (Fig. 6). In CO115 cells, a potential inhibition of RAS by sage extracts would 255 
not result in antiproliferative effects due to the downstream activating mutation of 256 
BRAF (Fig. 6). An inhibition of RAS oncogene has also been recently shown for 257 
quercetin, a common natural-occurring phenolic compound (32, 33). It seems that the 258 
effects of RA depend on cell type and/or genetic background, since also others have 259 
shown that RA decreases ERK phosphorylation in cardiac muscle cells but it is without 260 
effect on Akt and ERK in melanoma cells (34, 35).  261 
SF, SO and RA induced apoptosis in both cell lines. It seems, however, that 262 
under these conditions apoptosis is not dependent on the cleavage of neither caspase-9 263 
nor caspase-3 in both cell lines.  Nevertheless, some authors have shown that RA 264 
promotes apoptosis in human Jurkat cells and HepG2 cells via the mitochondrial 265 
pathway and Bcl-2 suppression in which caspases are involved (36-38).  Also the 266 
mitochondrial pathway was induced by RA in activated T cells from rheumatoid 267 
arthritis patients (39). It seems, therefore, that the induction of caspase pathways by RA 268 
is cell type specific and/or dependent on concentration and time of exposure which may 269 
explain the discrepancy between these and our results. The inhibition of MAPK/ERK 270 
pathway may contribute, at least in part, to the effects on apoptosis in HCT15 cells. 271 
Besides a possible interaction with KRAS, sage extracts may act as 272 
antiproliferative and proapoptotic in these cancer cell lines through their antioxidant 273 
activity. It is known that cancer cells produce increased amounts of ROS, in particularly 274 
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13 
hydrogen peroxide (H2O2), which could inhibit protein fosfatases and also be associated 275 
with signalling events in MAPK pathways that lead to activation of redox-sensitive 276 
transcription factors, mediating  cancer cell proliferation and survival (23, 24). 277 
Therefore, the radical scavenging activity of the phenolic compounds present in the sage 278 
extracts may be reducing the ROS levels in these cancer cells contributing also to a 279 
decreased activity of redox-sensitive proliferating pathways, through RAS signalling. 280 
Based on RA results, the effects describe in the present study seem, however, not to be 281 
totally explained by the antioxidant properties of the sage extracts.    282 
 In conclusion, our results show that SF and SO water extracts inhibit 283 
proliferation and induce apoptosis in colon carcinoma-derived cell lines whereas RA 284 
was only effective on the induction of apoptosis. Sage extracts and RA did not affect the 285 
PI3K/Akt pathway but inhibited the MAPK/ERK pathway in the KRAS mutated 286 
HCT15 cell line. The inhibitory effects of sage extracts on phospho-ERK seem to result 287 
from an inhibition of KRAS, upstream to BRAF, since it was not observed in CO115 288 
cells. The inhibition of MAPK/ERK by sage extracts seems, however, not to completely 289 
explain the inhibition of cell proliferation in HCT15, since RA inhibits phospho-ERK 290 
without affecting cell proliferation. These data add S. fruticosa and S. officinalis to the 291 
list of potential sources of new active anticancer compounds useful in particular in 292 
tumors with a mutagenic KRAS activation and also suggest their possible use in dietary 293 
strategies for the control of CRC progression.  294 
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Appendixes 
 
Figure 1. Chemical structure of rosmarinic acid (RA).  
 
Figure 2. Effect of different concentrations of Salvia fruticosa (SF), Salvia officinalis 
(SO) and rosmarinic acid (RA), for 48h, on BrdU incorporation in HCT15 (A) and 
CO115 (B) cells. Values are mean ± SEM of at least 3 independent experiments. *P≤ 
0.05 and ***P≤ 0.001 when compared to control.   
 
Figure 3. Effect of different concentrations Salvia fruticosa (SF), Salvia officinalis (SO) 
and rosmarinic acid (RA) on apoptosis, for 48h, as assessed by the TUNEL assay, of 
HCT15 (A) and CO115 (B) cell lines. Values are mean ± SEM of at least 3 independent 
experiments. *P≤ 0.05, **P≤ 0.01 and ***P≤ 0.001 when compared to control.  
 
Figure 4. Effects of Salvia fruticosa 50µg/ml (SF50), Salvia officinalis 50µg/ml (SO50) 
and rosmarinic acid 100µM (RA100) for 24h on the expression of phospho-ERK in 
HCT15 cells (A) and CO115 cells (B). PD-98059 50µM (PD50) was used as a reference 
inhibitor of phospho-ERK. Values are mean ± SEM of at least 3 independent 
experiments. *P≤ 0.05 and ***P≤ 0.001 when compared to control. 
 
Figure 5. Effects of Salvia fruticosa 50µg/ml (SF50), Salvia officinalis 50µg/ml (SO50) 
and rosmarinic acid 100µM (RA100) for 24h on the expression of phospho-Akt in 
CO115 cells (A) and phospho-PTEN in HCT15 cells (B). Wortmannin 1 µM (W1) was 
used as a reference inhibitor of PI3K. No phospho-Akt expression was observed in 
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21 
HCT15 cells and no PTEN expression was observed in CO115 cells. Values are mean ± 
SEM of at least 3 independent experiments. **P≤ 0.01 when compared to control.  
 
Figure 6. Model for the inhibition of ERK phosphorylation by Salvia fruticosa (SF), 
Salvia officinalis (SO) and rosmarinic acid (RA) in HCT15 but not in CO115 cells. SF, 
SO and RA inhibit mutant KRAS leading to a decrease on the levels of phospho-ERK in 
HCT15 cell line.  In CO115 cells, SF, SO and RA do not change ERK phosphorylation 
levels due to a BRAF activating mutation downstream RAS oncogene. The missing 
PTEN in CO115 cells and phospho-Akt in HCT15 cells were also observed in this 
study.  
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Chemical structure of rosmarinic acid (RA).  
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Effect of different concentrations of Salvia fruticosa (SF), Salvia officinalis (SO) and rosmarinic acid 
(RA), for 48h, on BrdU incorporation in HCT15 (A) and CO115 (B) cells. Values are mean ± SEM of 
at least 3 independent experiments. *P≤ 0.05 and ***P≤ 0.001 when compared to control.  
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Effect of different concentrations Salvia fruticosa (SF), Salvia officinalis (SO) and rosmarinic acid 
(RA) on apoptosis, for 48h, as assessed by the TUNEL assay, of HCT15 (A) and CO115 (B) cell lines. 
Values are mean ± SEM of at least 3 independent experiments. *P≤ 0.05, **P≤ 0.01 and ***P≤ 
0.001 when compared to control.  
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Effects of Salvia fruticosa 50µg/ml (SF50), Salvia officinalis 50µg/ml (SO50) and rosmarinic acid 
100µM (RA100) for 24h on the expression of phospho-ERK in HCT15 cells (A) and CO115 cells (B). 
PD-98059 50µM (PD50) was used as a reference inhibitor of phospho-ERK. Values are mean ± SEM 
of at least 3 independent experiments. *P≤ 0.05 and ***P≤ 0.001 when compared to control.  
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Effects of Salvia fruticosa 50µg/ml (SF50), Salvia officinalis 50µg/ml (SO50) and rosmarinic acid 
100µM (RA100) for 24h on the expression of phospho-Akt in CO115 cells (A) and phospho-PTEN in 
HCT15 cells (B). Wortmannin 1 µM (W1) was used as a reference inhibitor of PI3K. No phospho-Akt 
expression was observed in HCT15 cells and no PTEN expression was observed in CO115 cells. 
Values are mean ± SEM of at least 3 independent experiments. **P≤ 0.01 when compared to 
control.  
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Model for the inhibition of ERK phosphorylation by Salvia fruticosa (SF), Salvia officinalis (SO) and 
rosmarinic acid (RA) in HCT15 but not in CO115 cells. SF, SO and RA inhibit mutant KRAS leading to 
a decrease on the levels of phospho-ERK in HCT15 cell line. In CO115 cells, SF, SO and RA do not 
change ERK phosphorylation levels due to a BRAF activating mutation downstream RAS oncogene. 
The missing PTEN in CO115 cells and phospho-Akt in HCT15 cells were also observed in this study.  
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